Compare Stocks › ABBV vs VRSN

AbbVie Inc. (ABBV) vs VeriSign, Inc. (VRSN): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. VRSN is fairly valued at $307, with an intrinsic value of $291 and a margin of safety of -6%. Of the two, VRSN has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
VRSN
VeriSign, Inc.
$307.21

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
VRSN
  • ★Gross margin of 88.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★VeriSign, Inc. scores 100/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • ★Share count has been reduced by 13% over the past 4 years through buybacks, increasing each share's claim on earnings.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
VRSN
  • ⚠PEG ratio of 2.19 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • ⚠Altman Z-Score of -5.16 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • ⚠Insiders have sold $14.0M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
ABBV
VRSN
Valuation
N/A
Free Cash Flow
$1.07B
N/A
FCF Yield
3.88%
50.67
Trailing P/E
33.07
18.24
Forward P/E
28.02
Quality & Moat
29.08%
ROIC
52.40%
N/A
ROE
N/A
73.72%
Gross Margin
88.57%
0.60
PEG Ratio
2.19
Balance Sheet Safety
N/A
Net Debt / Equity
N/A
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.09
2.35%
Dividend Yield
1.05%
ABBV: 3Ties: 1VRSN: 4
ABBVVRSN

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

VRSN

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
VRSN
$0.31
created per $1 retained over 3 years
Value Destroyer
Σ Retained
$2.21B
Δ Market Cap
+$694.3M
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
VRSN
5.7% Overvalued
Price is 5.7% above estimated fair value
Current Price: $307.21
Fair Value: $290.53
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

VRSN

What growth rate is the market pricing in at $307?

+15.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.8%

The market implies +15.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +11.8%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
VRSN
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
VRSN
-3.13
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
VRSN
Insiders 10.6%Institutions 90.3%
No. of Institutional Holders1,306
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
VRSN
1
Buys (3M)
4
Buys (12M)
Total value (12M): $19,492
ARMSTRONG COURTNEY D.
Director
$5,671
@ $298.47 · 2026-08-27
ARMSTRONG COURTNEY D.
Director
$4,929
@ $308.06 · 2026-05-27
ARMSTRONG COURTNEY D.
Director
$4,912
@ $223.27 · 2026-02-27
ARMSTRONG COURTNEY D.
Director
$3,980
@ $265.33 · 2025-11-25
GORELICK JAMIE S
Director
$16,051
@ $267.52 · 2025-05-29
ARMSTRONG COURTNEY D.
Director
$3,969
@ $283.50 · 2025-05-28
BERKSHIRE HATHAWAY, INC.
Beneficial Owner of more than 10% of a Class of Security
$4.10M
@ $204.71 · 2025-01-03
BERKSHIRE HATHAWAY, INC.
Beneficial Owner of more than 10% of a Class of Security
$15.57M
@ $203.62 · 2024-12-30
BERKSHIRE HATHAWAY, INC.
Beneficial Owner of more than 10% of a Class of Security
$28.55M
@ $199.05 · 2024-12-24
BERKSHIRE HATHAWAY, INC.
Beneficial Owner of more than 10% of a Class of Security
$45.40M
@ $193.77 · 2024-12-19
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
VRSN
17
Sells (3M)
54
Sells (12M)
Total value (12M): $37.13M
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$1.00M
@ $303.67 · 2026-10-27
MCPHERSON DANNY R
Officer
$989,482
@ $303.89 · 2026-10-26
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$1.01M
@ $306.30 · 2026-10-20
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$999,404
@ $302.85 · 2026-10-13
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$964,691
@ $292.33 · 2026-10-06
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$919,976
@ $278.78 · 2026-09-29
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$1.01M
@ $304.74 · 2026-09-22
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$978,713
@ $296.58 · 2026-09-15
INDELICARTO THOMAS C
Officer
$144,580
@ $289.16 · 2026-09-08
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$938,525
@ $284.40 · 2026-09-08
INDELICARTO THOMAS C
General Counsel
$145,390
@ $290.78 · 2026-09-01
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$960,592
@ $291.09 · 2026-09-01
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$960,812
@ $291.16 · 2026-08-25
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$916,910
@ $277.85 · 2026-08-18
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$963,549
@ $291.98 · 2026-08-11
INDELICARTO THOMAS C
Officer
$146,175
@ $292.35 · 2026-08-10
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$978,591
@ $296.54 · 2026-08-04
INDELICARTO THOMAS C
Officer
$146,100
@ $292.20 · 2026-08-03
CALYS JOHN D
Chief Financial Officer
$140,778
@ $281.56 · 2026-07-28
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$927,964
@ $281.20 · 2026-07-28
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$892,466
@ $270.44 · 2026-07-21
INDELICARTO THOMAS C
General Counsel
$140,000
@ $280.00 · 2026-07-20
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$883,875
@ $267.84 · 2026-07-14
INDELICARTO THOMAS C
General Counsel
$67,308
@ $269.23 · 2026-07-08
BIDZOS DEMETRIOS JAMES
President
$878,105
@ $266.09 · 2026-07-07
INDELICARTO THOMAS C
General Counsel
$63,958
@ $255.83 · 2026-07-01
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$828,110
@ $250.94 · 2026-06-30
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$820,141
@ $248.53 · 2026-06-23
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$904,926
@ $274.22 · 2026-06-16
INDELICARTO THOMAS C
General Counsel
$141,770
@ $283.54 · 2026-06-09
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$938,169
@ $284.29 · 2026-06-09
INDELICARTO THOMAS C
General Counsel
$146,725
@ $293.45 · 2026-06-02
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$981,646
@ $297.47 · 2026-06-02
MCPHERSON DANNY R
Officer
$1.36M
@ $271.02 · 2026-04-28
INDELICARTO THOMAS C
General Counsel
$134,490
@ $270.06 · 2026-04-14
INDELICARTO THOMAS C
General Counsel
$136,452
@ $274.00 · 2026-04-07
INDELICARTO THOMAS C
General Counsel
$124,500
@ $250.00 · 2026-03-25
INDELICARTO THOMAS C
General Counsel
$79,886
@ $240.62 · 2026-03-10
INDELICARTO THOMAS C
General Counsel
$115,426
@ $231.78 · 2026-03-03
INDELICARTO THOMAS C
General Counsel
$36,394
@ $219.24 · 2026-02-10
INDELICARTO THOMAS C
General Counsel
$124,042
@ $249.08 · 2026-02-03
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.24M
@ $248.45 · 2026-01-15
INDELICARTO THOMAS C
General Counsel
$123,859
@ $248.71 · 2026-01-13
INDELICARTO THOMAS C
General Counsel
$41,500
@ $250.00 · 2026-01-09
INDELICARTO THOMAS C
General Counsel
$79,956
@ $240.83 · 2026-01-06
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.19M
@ $243.06 · 2025-12-18
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.20M
@ $244.00 · 2025-12-11
INDELICARTO THOMAS C
General Counsel
$125,285
@ $250.07 · 2025-12-09
INDELICARTO THOMAS C
General Counsel
$126,563
@ $252.62 · 2025-12-02
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.24M
@ $248.73 · 2025-11-20
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.25M
@ $249.88 · 2025-11-13
INDELICARTO THOMAS C
General Counsel
$165,821
@ $248.24 · 2025-11-12
CALYS JOHN D
Chief Financial Officer
$242,955
@ $242.71 · 2025-11-07
INDELICARTO THOMAS C
General Counsel
$81,670
@ $244.52 · 2025-11-04
MCPHERSON DANNY R
Officer
$592,175
@ $236.87 · 2025-10-31
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.36M
@ $262.18 · 2025-10-23
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.38M
@ $264.40 · 2025-10-16
INDELICARTO THOMAS C
General Counsel
$131,723
@ $262.92 · 2025-10-14
INDELICARTO THOMAS C
General Counsel
$135,706
@ $270.87 · 2025-10-07
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$575,925
@ $287.96 · 2025-09-18
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.01M
@ $287.67 · 2025-09-17
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.56M
@ $284.36 · 2025-09-11
INDELICARTO THOMAS C
General Counsel
$141,422
@ $282.28 · 2025-09-09
INDELICARTO THOMAS C
General Counsel
$135,500
@ $270.46 · 2025-09-02
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.43M
@ $269.68 · 2025-08-21
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.39M
@ $265.18 · 2025-08-14
INDELICARTO THOMAS C
General Counsel
$132,514
@ $264.50 · 2025-08-12
INDELICARTO THOMAS C
General Counsel
$135,020
@ $269.50 · 2025-08-05
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.54M
@ $281.70 · 2025-07-17
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.58M
@ $286.22 · 2025-07-10
INDELICARTO THOMAS C
General Counsel
$143,837
@ $287.10 · 2025-07-08
INDELICARTO THOMAS C
General Counsel
$145,373
@ $290.17 · 2025-07-01
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.55M
@ $282.87 · 2025-06-18
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.50M
@ $278.29 · 2025-06-12
INDELICARTO THOMAS C
General Counsel
$140,541
@ $280.52 · 2025-06-10
INDELICARTO THOMAS C
General Counsel
$137,995
@ $275.44 · 2025-06-03
INDELICARTO THOMAS C
General Counsel
$141,282
@ $282.00 · 2025-05-27
BIDZOS DEMETRIOS JAMES
Chief Executive Officer
$2.53M
@ $280.73 · 2025-05-22
INDELICARTO THOMAS C
General Counsel
$141,172
@ $281.78 · 2025-05-20
BUCHALTER YEHUDA ARI
Director
$170,274
@ $283.79 · 2025-05-06
CALYS JOHN D
Officer
$112,788
@ $281.97 · 2025-05-02
CALYS JOHN D
Officer
$103,590
@ $231.74 · 2025-02-24
COTE KATHLEEN A
Director
$690,000
@ $230.00 · 2025-02-18
MCPHERSON DANNY R
Officer
$1.27M
@ $230.73 · 2025-02-18
MCPHERSON DANNY R
Officer
$402,573
@ $192.43 · 2024-12-02
CALYS JOHN D
Officer
$198,800
@ $186.49 · 2024-11-07
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
VRSN
FearGreed
😏Greed(67/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
VRSN
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (67)
View ABBV Full AnalysisView VRSN Full Analysis

Frequently Asked Questions: ABBV vs VRSN

Is AbbVie Inc. or VeriSign, Inc. more undervalued in 2026?▼

Based on our discounted cash flow model, VRSN trades at a -5.7% margin of safety (intrinsic value $291 vs. price $307), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or VeriSign, Inc.?▼

VRSN scores 100/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is VeriSign, Inc. in financial distress?▼

VRSN's Altman Z-Score of -5.2 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or VeriSign, Inc.?▼

VRSN earns 52.4% ROIC versus ABBV's 29.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or VeriSign, Inc.'s?▼

VRSN's dividend earns a safety score of 85/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). VRSN has raised its dividend for 0 consecutive years.